Disinfectant caps lower CLABSI cases and costs

Using disinfectant caps on intravenous needleless connectors led to a 40 percent drop in central line–associated bloodstream infections, according to a recent study published in the American Journal of Infection Control.

Advertisement

For the study, a new intervention of using a luer-lock disinfectant cap with 70 percent alcohol was implemented in all IV needleless connectors for patients with peripheral and central lines in a trauma center.

The new disinfectant caps, along with the use of a standard central line bundle, led to a roughly 40 percent decrease in CLABSIs.

In addition to lowering infection rates, the use of the disinfectant caps was associated with an estimated savings of nearly $300,000 a year in the hospital studied.

 

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.